• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Arch Pathol Lab Med . Highlighted prospects of an IgM/IgG antibodies test in identifying individuals with asymptomatic SARS CoV-2 infection

tetano

Editor, Senior Moderator
Arch Pathol Lab Med


. 2020 Sep 23.
doi: 10.5858/arpa.2020-0310-SA. Online ahead of print.
Highlighted prospects of an IgM/IgG antibodies test in identifying individuals with asymptomatic SARS CoV-2 infection


Yaqing Li[SUP] 1 [/SUP], Qiang He[SUP] 1 [/SUP], Rizhen Yu[SUP] 1 [/SUP], Hui Jiang[SUP] 1 [/SUP], Weizhong Wang[SUP] 1 [/SUP], Dujin Feng[SUP] 1 [/SUP], Guanghua Hou[SUP] 1 [/SUP], Hongbin Zhou[SUP] 1 [/SUP], Yaona Jiang[SUP] 1 [/SUP], Zhun Xiang[SUP] 1 [/SUP]



Affiliations

Abstract

Context, Covert severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections could be seeding new outbreaks. How to identify asymptomatic SARS-CoV-2 infections early has become a global focus. Objective, To explore the roles of immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies detection, nucleic acid tests and computed tomography (CT) scanning to identify asymptomatic SARS-CoV-2 infection. Design, The clinical data of 389 individuals with close contacts including in general characteristics, SARS-CoV-2 etiology, serum-specific IgM and IgG antibody detection and CT imaging results, were systematically analyzed. Results, The present study showed that only 89 of the 389 individuals with close contacts were positive after the first nucleic acid test, while 300 individuals were still negative after two nucleic acid tests. Among the 300 individuals, 75 did not have pneumonia, and the other 225 individuals had pulmonary imaging changes. A total of 143 individuals were eventually diagnosed as having asymptomatic infection through IgM antibody and IgG antibody detection. The sensitivity, specificity and false-negative rate of IgM and IgG antibody detection were approximately 97.1% (347/357), 95.3% (204/214) and 4.67% (10/214), respectively. It also indicated that over approximately 2 weeks, most individuals were both IgM positive and IgG positive, accounting for 68.57% (72/105). Over approximately 3 weeks, the proportion of IgM-positive and IgG-positive individuals decreased to 8.57% (9/105), and the proportion of IgM-negative and IgG-positive individuals increased to 76.19% (80/105). Conclusions, There are highlighted prospects of IgM/IgG antibody detection as a preferred method in identifying the individuals with asymptomatic SARS CoV-2 infection, especially combined with nucleic acid tests and pulmonary CT scanning.

Keywords: COVID-19; IgG; IgM; SARS-CoV-2; asymptomatic infection.
 
Back
Top Bottom